SCHEMBL8282965

SCHEMBL8282965

CC(C)(C)OC(=O)N[C@H](CN1Cc2ccccc2S1(=O)=O)C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PER2 O15055 1/20 0.45
CRY1 Q16526 1/20 0.45
CRY2 Q49AN0 1/20 0.45
CACNA1H O95180 2/20 0.43
KCNH2 Q12809 1/20 0.43
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
NAMPT P43490 2/20 0.38
TDP1 Q9NUW8 1/20 0.37
PPARA Q07869 3/20 0.36
CTSK P43235 2/20 0.36
PPARG P37231 2/20 0.36
ATM Q13315 2/20 0.36
CTSS P25774 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRL1 P41146 1/20 0.36
ACE P12821 1/20 0.36
DRD2 P14416 3/20 0.36
PPARD Q03181 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13622666 1.00 PER2 (0.45) PER2CRY1CRY2CACNA1HKCNH2
SCHEMBL8036660 0.81 CTSK (0.34) NAMPTPPARACTSKPPARGATM
SCHEMBL13622653 0.81 CTSK (0.34) NAMPTPPARACTSKPPARGATM
SCHEMBL8270195 0.81 PER2 (0.49) PER2CRY1CRY2CACNA1HKCNH2
SCHEMBL13622671 0.76 TPSAB1 (0.54) TDP1
SCHEMBL8282041 0.76 TPSAB1 (0.54) TDP1
SCHEMBL13622796 0.74 KDM4E (0.44) PER2CRY2NAMPTCTSKCTSS
SCHEMBL13622813 0.74 KDM4E (0.44) PER2CRY2NAMPTCTSKCTSS
SCHEMBL8282107 0.74 KDM4E (0.44) PER2CRY2NAMPTCTSKCTSS
SCHEMBL8242189 0.73 PER2 (0.51) PER2CRY1CRY2CACNA1HKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730142-B1 NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS SCHERING CORP (US) 2011-06-29 EP disclosed
WO-2005085242-A1 NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS SCHERING CORPORATION (US) 2005-09-15 WO disclosed